Dr. Imran Yaseen Gani, MD

Dr. Gani practices at Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System.

Dr. Gani's NPI, 1427336742, was assigned on August 3, 2011. Dr. Gani graduated from Other in 2007. Dr. Gani holds Georgia license 078542.

Dr. Gani's primary practice is Wellstar MCG Health Medical Center, at 1120 15th Street, Augusta, GA 30912 in Richmond County. The practice phone is (706) 721-6569.

Dr. Gani's primary practice is Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System. Dr. Gani is also affiliated with Piedmont Augusta. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Gani to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gani practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Gani's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gani is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gani's licenses on file in 3 states: Georgia, South Carolina and Pennsylvania.

CMS data shows 419 Medicare services from Dr. Gani across 5 procedure codes in 2024, for 191 Medicare patients. Medicare paid $28,723 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 191 Medicare patients who saw Dr. Gani in 2024. The largest group is under 65, with 103 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 37% are also on Medicaid. Their average risk score is 5.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gani's median patient age at 59, with 45% women.

In 2024, Dr. Gani wrote 1,237 Medicare Part D claims for 159 patients. 86% of them were for generic drugs. CMS names the drug for 991 of them, across 34 drugs with 11 or more claims each, at $479,025 in total drug cost. In 2023, CMS named 1,440 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Gani for performance year 2024, reported through an alternative payment model (APM). Dr. Gani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 32 papers to Dr. Gani, published from 2017 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Kidney Transplantation, Graft Rejection and Immunosuppression Therapy. Dr. Gani has published most often in Am J Med Sci. Dr. Gani's most frequent co-authors are Ahmad Karim Mirza, MD, Sreedhar Reddy Adapa, MD and Jeffrey M. Burns, MD.

Dmand AI links Dr. Gani to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Renal Insufficiency, Chronic and Renal Insufficiency.

CMS Open Payments shows 91 general payments to Dr. Gani from 31 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. AstraZeneca Pharmaceuticals LP paid the most, $339.

Dr. Gani graduated from Other in 2007.

Dr. Gani is in network with 17 carriers, including Aetna, HCSC and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.